Advertisement

Topics

KalVista Pharmaceuticals Reports Fiscal First Quarter Results

11:41 EDT 14 Sep 2018 | Investing News Network

KalVista Pharmaceuticals (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, provided an operational update and released financial results for the fiscal first quarter ended July 31, 2018. As quoted in the press release: “Our two recent financings provide significant additional capital for late stage development … Continued

The post KalVista Pharmaceuticals Reports Fiscal First Quarter Results appeared first on Investing News Network.

Original Article: KalVista Pharmaceuticals Reports Fiscal First Quarter Results

NEXT ARTICLE

More From BioPortfolio on "KalVista Pharmaceuticals Reports Fiscal First Quarter Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...